LncRNA HEIH/miR-4500/IGF2BP1/c-Myc反循环加速膀癌细胞生长和干细胞的形成
Baowei Guo1, Dan Zhao1, Jiao Feng2
1Department of Urology, Yidu Central Hospital of Weifang, Qingzhou City, Weifang, Shandong, China.
Bladder cancer (Amsterdam, Netherlands)
|July 12, 2024
概括
肝细胞癌上调的EZH2相关 lncRNA (HEIH) 通过上调c-Myc促进膀癌的进展. 这项研究揭示了HEIH/miR-4500/IGF2BP1/c-Myc反循环,为膀癌提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 膀癌 (BCa) 是一种流行恶性瘤,在男性中更为常见.
- 长非编码RNA (lncRNA) 肝细胞癌上调调 EZH2-关联 lncRNA (HEIH) 在BCa进展中的作用基本上是未知的.
研究的目的:
- 研究HEIH在膀癌进展中的作用和调控机制.
- 为了确定HEIH是否影响BCa细胞的增殖,细胞亡,迁移,入侵和干性.
主要方法:
- 定量实时聚合酶链反应 (RT-qPCR) 来评估BCa细胞系中的HEIH表达.
- 功能性测试,以评估HEIH对BCa细胞行为的影响.
- 生物信息学和机械学实验以阐明分子相互作用.
主要成果:
- 在BCa细胞系中,HEIH的表达显著升高.
- 消耗HEIH抑制BCa细胞的增殖,迁移和入侵.
- HEIH上调调节c-Myc表达,促进BCa细胞干细胞的形成.
- HEIH作为miR-4500的海绵,调节IGF2BP1并稳定c-Myc mRNA.
结论:
- 一个涉及HEIH/miR-4500/IGF2BP1/c-Myc的积极反循环驱动了BCa的进展.
- 这个调节轴为膀癌提供了一个新的治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


